Twist Bioscience
TWST
240 hedge funds and large institutions have $5.82B invested in Twist Bioscience in 2021 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 91 increasing their positions, 75 reducing their positions, and 32 closing their positions.
56% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 32
21% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 75
8% more funds holding
Funds holding: 223 → 240 (+17)
6.97% more ownership
Funds ownership: 89.64% → 96.61% (+7%)
4% less capital invested
Capital invested by funds: $6.07B → $5.82B (-$243M)
29% less call options, than puts
Call options by funds: $21.6M | Put options by funds: $30.3M
56% less funds holding in top 10
Funds holding in top 10: 9 → 4 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
+$242M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$194M |
| 3 |
BlackRock
New York
|
+$84.4M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$78M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$66.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$62.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$53.4M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$48.3M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$43.7M |
| 5 |
TCM
Tao Capital Management
San Francisco,
California
|
-$41.8M |
TWST Hedge Fund Activity: Q1 2021 in Review
240 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q1 2021, worth a combined $5.82B — down 4% from $6.07B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new TWST positions and 32 closed out — a net gain of 18 holders — while 91 added to existing stakes and 75 trimmed.
The largest buyer was Allianz Asset Management, adding an estimated $242M. The largest seller was Lord, Abbett & Co, cutting an estimated $62.6M.
- 240 institutional investors held Twist Bioscience (TWST) as of Q1 2021, up from 223 in Q4 2020.
- Funds reported $5.82B of Twist Bioscience stock for Q1 2021, down 4% quarter-over-quarter.
- 50 funds opened new Twist Bioscience positions in Q1 2021 and 32 closed out, a net change of +18 holders.
- The largest Twist Bioscience buyer in Q1 2021 was Allianz Asset Management, an estimated $242M added.
- The largest Twist Bioscience seller in Q1 2021 was Lord, Abbett & Co, an estimated $62.6M sold.
Based on aggregated 13F filings for Q1 2021.